Early Detection of Familial Hypercholesterolemia in Children

Heterozigous FH is an underdiagnosed disease in the paediatric population. Its early detection, would allow us to initiate lifestyle therapeutical changes and early pharmacological therapy if necessary. This is a key fact to reduce atherosclerosis progression and cardiovascular risk in adulthood. Moreover, it will allow, detecting the first and second degree affected relatives.

NCT Number	NCT04370899
Lead Sponsor	Institut Investigacio Sanitaria Pere Virgili
Conditions	Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Familial Hypercholesterolemia - Homozygous
Enrollment	400 participants
Start Date	2013-03-14
Primary Completion	2030-03-14 (estimated)
Study Completion	2030-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-18